VIVS

VivoSim Labs Inc

• TipRanks·4d ago

  VivoSim Labs Prices Best-Efforts Public Offering

• Reuters·4d ago

  VivoSim prices up to $4 million best-efforts public offering at $1.14 a share

• NASDAQ·6d ago

  VivoSim Labs Fall 34% After Pricing Up To $4 Million Public Offering

• Benzinga·6d ago

  VivoSim Labs Announces The Pricing Of Up To A $4M Best-Efforts Public Offering, With $3M Funded At An Initial Closing Of The Offering

• Reuters·6d ago

  VivoSim Labs prices up to $4 million best-efforts public offering

• Seeking Alpha·03/30 15:01

  VivoSim launches $4M offering with warrants and two-tranche structure

• TipRanks·03/27 21:35

  VivoSim files to sell 2.37M shares of common stock, pre-funded warrants

• Benzinga·03/24 12:20

  VivoSim Labs Announces Its NAMkind Liver, Intestine Models Validated For Predicting Toxicity, Side Effect Profiles Of Antibody Drug Conjugates

• Reuters·03/24 12:06

  VivoSim validates NAMkind liver and intestine models for predicting ADC toxicity profiles

• TipRanks·03/03 13:34

  VivoSim appoints Arumugham Raghunathan as VP, global sales

• Reuters·03/03 13:05

  VivoSim Labs Names Arumugham Raghunathan VP of Global Sales

• Reuters·03/03 13:05

  VIVOSIM APPOINTS ARUMUGHAM (RAGOO) RAGHUNATHAN AS VICE PRESIDENT OF GLOBAL SALES

• Dow Jones·03/03 13:05

  Press Release: VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales

• Benzinga·02/20 21:05

  12 Health Care Stocks Moving In Friday's After-Market Session

• TipRanks·02/11 13:22

  VivoSim to debut antibody drug conjugate data at SOT meeting